Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01591590
What this trial is testing

Correlating the Tumoral Metabolic Progression Index to Patient's Outcome in Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jules Bordet Institute 53
Large-scale testing (Phase 3)Looking for participantsNCT07185997
What this trial is testing

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Who this might be right for
Non-Small-Cell Lung CancerMetastatic Non-Small-Cell Lung CancerAdvanced Non-Small-Cell Lung Cancer+3 more
ArriVent BioPharma, Inc.
Early research (Phase 1)Study completedNCT06056024
What this trial is testing

Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Who this might be right for
Solid Tumor, KRAS Mutation
Boehringer Ingelheim 47
Testing effectiveness (Phase 2)Study completedNCT02725424
What this trial is testing

Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer

Who this might be right for
Gastric Cancer
Chinese Academy of Medical Sciences 180
Early research (Phase 1)Study completedNCT00741403
What this trial is testing

A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies

Who this might be right for
Advanced CancerMetastatic CancerLymphoma+2 more
Cornerstone Pharmaceuticals 39
Testing effectiveness (Phase 2)Looking for participantsNCT05487170
What this trial is testing

RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)

Who this might be right for
Advanced Solid TumorDLBCL
Ranok Therapeutics (Hangzhou) Co., Ltd. 32
Early research (Phase 1)Active Not RecruitingNCT05068102
What this trial is testing

Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck (HNSCC)MelanomaNon-small Cell Lung Cancer (NSCLC)
Boehringer Ingelheim 14
Early research (Phase 1)Study completedNCT01012102
What this trial is testing

EMD 640 744 in Montanide ISA 51 VG Administered in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Merck KGaA, Darmstadt, Germany 104
Early research (Phase 1)Looking for participantsNCT05614739
What this trial is testing

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Who this might be right for
Urinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms
Eli Lilly and Company 677
Testing effectiveness (Phase 2)Study completedNCT01218477
What this trial is testing

Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML)

Who this might be right for
Leukemia
Bristol-Myers Squibb 33
Testing effectiveness (Phase 2)Study completedNCT01531777
What this trial is testing

Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jiangsu HengRui Medicine Co., Ltd. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06237881
What this trial is testing

KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMelanomaLung Neoplasms+1 more
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT02417701
What this trial is testing

Sapanisertib in Treating Patients With Stage IV or Recurrent Lung Cancer

Who this might be right for
Recurrent Lung Squamous Cell CarcinomaStage IV Lung Squamous Cell Carcinoma AJCC v7
National Cancer Institute (NCI) 34
Early research (Phase 1)Active Not RecruitingNCT04606381
What this trial is testing

Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 158
Testing effectiveness (Phase 2)Ended earlyNCT01234519
What this trial is testing

A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy

Who this might be right for
Urothelial Carcinoma
AEterna Zentaris 12
Very early researchEnded earlyNCT04601428
What this trial is testing

Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Koo Foundation Sun Yat-Sen Cancer Center 12
Early research (Phase 1)Study completedNCT05226728
What this trial is testing

Pharmacokinetically-guided on the Individualization of Pembrolizumab Administration in the Treatment of Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 33
Not applicableWithdrawnNCT03115528
What this trial is testing

Difference in the Estimation of Prognosis

Who this might be right for
Malignant Neoplasms of Independent (Primary) Multiple Sites
M.D. Anderson Cancer Center
Early research (Phase 1)Looking for participantsNCT07514065
What this trial is testing

TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer Patients
Tasly Pharmaceutical Group Co., Ltd 78
Early research (Phase 1)UnknownNCT02300467
What this trial is testing

NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors

Who this might be right for
Advanced Refractory Solid Tumors
National OncoVenture 30
Next Page
480